CAS: 37148-27-9; Clenbuterol

该化合物是一种结构上独特的芳香氨醇,具有氨基和羟基功能组,在苯环上存在电排氯替代成分,加强了其在选择性合成应用中的稳定性和回活动性.二丁基氨基基元素会助长消毒障碍,影响其在潜在药理环境中的结合性.这一化合物对医药化学具有兴趣,因为它具有作为β-Adnergic受体调制器中间体的潜力.其定义明确的分子结构可以进行精确的修改,使其成为开发定向生物活性分子的宝贵搭载体.高纯度和一致的合成协议确保研究和工业应用的再生性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4'-amino-2-(t-butylamino)-3',5'-dichloroacetophenone hydr°Chloride rac-1-(4-aminophenyl)-2-(tert-butylamino)ethanol 2-(4-amino-3,5-dichlorophenyl)-N-(tert-butyl)-2-oxoacetamide 2,6-dichloro-4-iodoanilineN-[2-(4-Amino-3,5-dichloro-phenyl)-2-(1,2-dimethyl-propyl-dimethyl-silyloxy)-ethyl]-N-t-butylamine 5-(4-amino-3,5-dichlorophenyl)-3-tert-butyl-2-oxazolidinone (+)-Clenbuterol

合成工艺路线路线简述

  • 合成目标产物 Clenbuterol 主要起始原料 4-Amino-3,5-Dichlorophenacylbromide And Tert-Butylamine
  • (文献来源)合成步骤主要原料 4-Amino-3,5-Dichlorophenacylbromide 和 Tert-Butylamine
📜2,6-二氯-4-碘苯胺置于sodium Tetrahydroborate,三叔丁基膦,N-甲基二环己基胺,碘,Bis(Dibenzylideneacetone)-Palladium(0)体系中,用 四氢呋喃,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 16.0H,反应生成 克仑特罗
参考文献:使用接近化学计量的一氧化碳进行钯催化的双羰基化:方便地获得取代的13 C 2标签的苯乙胺
标题:使用接近化学计量的一氧化碳进行钯催化的双羰基化:方便地获得取代的13 C 2标签的苯乙胺
摘要:基于高度收敛的碳骨架一步组装,已开发出一种新颖且通用的13 C 2-和2 H标记的苯乙胺衍生物的方法.使用钯催化的具有接近化学计量的一氧化碳的芳基碘化物的双羰基化作用,可以将两个碳13同位素有效地结合到苯乙胺中.
DOI:10.1021/jo3009337

海关参考信息

专利信息


专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:WO-2025056767-A1
优先权日:2023-09-15
标题 :Process for the preparation of enantiomerically enriched aliphatic amines
发明人:BOU HAMDAN FARHAN; GODINEAU EDOUARD; SMEJKAL TOMAS; DUMEUNIER RAPHAEL; BOUSSEMGHOUNE MOHAMED ABDELOUAHAB; BLUM MATHIAS
权利人:SYNGENTA CROP PROTECTION AG
摘要:The present invention relates to a process for the preparation of enantiomerically enriched cyclobutylamines of formula (I) from α-tertiary cyclobutanones and reacting said enantiomerically enriched cyclobutylamines to enantiomerically enriched cyclobutylamides. Such compounds are useful intermediates in the synthesis of microbiocidal thiazole compounds.

专利号:US-8017776-B2
优先权日:2003-07-15
标题 :Methods for synthesis of acyloxyalkyl compounds
发明人:BHAT LAXMINARAYAN; GALLOP MARK A
权利人:XENOPORT INC
摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

专利号:US-8143437-B2
优先权日:2002-02-19
标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

专利号:US-9757463-B2
优先权日:2012-06-15
标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M
权利人:UNIV VANDERBILT
摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

专利号:US-2006165683-A1
优先权日:2001-12-05
标题:Methods and compositions for control of bone formation via modulation of sympathetic tone
发明人:KARSENTY GERARD; TAKEDA SHU; ELEFTERIOU FLORENT
权利人:KARSENTY GERARD; TAKEDA SHU; ELEFTERIOU FLORENT
摘要:This invention relates to methods for treatment, diagnosis and prevention of bone disease and comprises methods including measurement and modulation of sympathetic tone and leptin activity. Alteration of sympathetic tone in bone disease can be accomplished by decreasing or increasing leptin synthesis, leptin receptor synthesis, leptin binding to the leptin receptor, and leptin receptor activity. Alteration of sympathetic tone in bone disease can also be accomplished in the foregoing manner, in combination with traditional sympathetic nervous system agonists and/or antagonists, such as, but not limited to, a dopamine β hydroxylase antagonist or a β adrenergic antagonist for treatment or prevention of osteoporosis.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Zahn V, Krumbachner G. Clenbuterol - A long term uterine relaxant. J Perinat Med. 2023 Nov 2;9(2):96-100. doi: 10.1515/jpm-1981-090201. 27(1):98. doi: 10.1186/s40824-023-00432-4.
3: Hu D, Li H, Yu H, Zhao M, Ye L, Liu B, Ge N, Dong N, Wu L. Clenbuterol Prevents Mechanical Unloading-Induced Myocardial Atrophy via Upregulation of Transient Receptor Potential Channel-3. Int Heart J. 2023;64(5):901-909. doi: 10.1536/ihj.21-129.
14:1252508. doi: 10.3389/fphys.2023.1252508.

合成参考文献


参考文献:10.1007/s11596-010-0106-4
摘要:Wang H, Zhao H, Ye Y, Xiong N, Huang J, Yao D, Shen Y, Zhao X. Focal cerebral ischemia induces Alzheimer's disease-like pathological change in rats. J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):29–36. doi: 10.1007/s11596-010-0106-4.
参考文献:10.1007/s00216-010-3484-3
摘要:Peters RJB, Oosterink JE, Stolker AAM, Georgakopoulos C, Nielen MWF. Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Analytical and Bioanalytical Chemistry. 2010 Feb 16;396(7):2583–98. doi: 10.1007/s00216-010-3484-3.
参考文献:10.1186/1472-6750-10-12
摘要:Zhong L, Zhang W, Zer C, Ge K, Gao X, Kernstine KH. Protein microarray: sensitive and effective immunodetection for drug residues. BMC Biotechnol. 2010 Feb 16;10():12.
参考文献:10.1007/s11373-005-9019-9
摘要:Chou CH, Tsai YL, Hou CW, Lee HH, Chang WH, Lin TW, Hsu TH, Huang YJ, Kuo CH. Glycogen overload by postexercise insulin administration abolished the exercise-induced increase in GLUT4 protein. J Biomed Sci. 2005 Dec;12(6):991–8. doi: 10.1007/s11373-005-9019-9.
参考文献:10.1111/j.1440-1681.2011.05574.x
摘要:Head SI, Ha TN. Acute inhibitory effects of clenbuterol on force, Ca2+transients and action potentials in rat soleus may not involve the β2‐adrenoceptor pathway. Clin Exp Pharma Physio. 2011 Aug 26;38(9):638–46. doi: 10.1111/j.1440-1681.2011.05574.x.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知